Oasima Pharmaceutical AB has announced that Fredrik
Gynnerstedt has been appointed the company’s new CFO.
“I’m happy to join the team at Oasmia, a company currently
in an exciting phase as it pursues global commercialization via its robust
pipeline of pharmaceutical products,” Gynnerstedt said. “I’m looking forward to
contributing to the continued success of the company in my new capacity as
chief financial officer.”
Gynnerstedt has 15 years of experience working in
international business administration and related activities. He previously
served as Karnov Group’s Director of Collaboration, the CFO for Bringwell AB
and as an auditor and consultant at Ernst & Young. Gynnerstedt earned his
Master’s in Business and Administration from Stockholm University.
Gynnerstedt will take over as the CFO for Oasima on Dec.
1 and will also become a member of Oasima’s management team.
Oasmia Pharmaceutical specializes in human and veterinary oncology drugs.
Oasima names Fredrik Gynnerstedt CFO
Alerts Sign-up